Lei Z, Song S, Geng Y, Liu B, Li Y, Min H
RSC Med Chem. 2025; .
PMID: 40008188
PMC: 11848403.
DOI: 10.1039/d4md00940a.
Zhang P, Tao C, Xie H, Yang L, Lu Y, Xi Y
Gastric Cancer. 2025; .
PMID: 39918687
DOI: 10.1007/s10120-025-01584-z.
Li Y, Song X, Huang Y, Zhou S, Zhong L
Sci Rep. 2025; 15(1):1377.
PMID: 39779799
PMC: 11711443.
DOI: 10.1038/s41598-025-85664-1.
Yan J, Zhang C, Xu Y, Huang Z, Ye Q, Qian X
Nat Immunol. 2024; 25(11):2057-2067.
PMID: 39358444
DOI: 10.1038/s41590-024-01973-z.
Peng Y, Wang L, Yang J, Wu Q, Sun X, Zhang J
Front Pharmacol. 2024; 15:1466779.
PMID: 39351094
PMC: 11439782.
DOI: 10.3389/fphar.2024.1466779.
A Novel Tumor-Associated Neutrophil-Related Risk Signature Based on Single-Cell and Bulk RNA-Sequencing Analyses Predicts the Prognosis and Immune Landscape of Breast Cancer.
Yin S, Li C, Zhang Y, Yin H, Fan Z, Ye X
J Cancer. 2024; 15(17):5655-5671.
PMID: 39308692
PMC: 11414621.
DOI: 10.7150/jca.100338.
Small data methods in omics: the power of one.
Johnston K, Grieco S, Nie Q, Theis F, Xu X
Nat Methods. 2024; 21(9):1597-1602.
PMID: 39174710
DOI: 10.1038/s41592-024-02390-8.
Integrative and comprehensive pan-cancer analysis of ubiquitin specific peptidase 11 () as a prognostic and immunological biomarker.
Cui L, Yang L, Lai B, Luo L, Deng H, Chen Z
Heliyon. 2024; 10(14):e34523.
PMID: 39114046
PMC: 11305246.
DOI: 10.1016/j.heliyon.2024.e34523.
NCAPD2 augments the tumorigenesis and progression of human liver cancer via the PI3K‑Akt‑mTOR signaling pathway.
Gu J, Huang K, Zhao W, Zheng X, Wu Y, Yan S
Int J Mol Med. 2024; 54(4).
PMID: 39092569
PMC: 11315656.
DOI: 10.3892/ijmm.2024.5408.
Bioinformatics tools and resources for cancer and application.
Huang J, Mao L, Lei Q, Guo A
Chin Med J (Engl). 2024; 137(17):2052-2064.
PMID: 39075637
PMC: 11374212.
DOI: 10.1097/CM9.0000000000003254.
Review: Cancer and neurodevelopmental disorders: multi-scale reasoning and computational guide.
Nussinov R, Yavuz B, Demirel H, Arici M, Jang H, Tuncbag N
Front Cell Dev Biol. 2024; 12:1376639.
PMID: 39015651
PMC: 11249571.
DOI: 10.3389/fcell.2024.1376639.
Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody.
Roider H, Hoff S, Tseng S, Berndt S, Trautwein M, Filarsky K
Clin Exp Med. 2024; 24(1):122.
PMID: 38856863
PMC: 11164760.
DOI: 10.1007/s10238-024-01362-8.
An integrated analysis revealing the angiogenic function of TP53I11 in tumor microenvironment.
Bai W, Ren J, Li K, Jiang Q
Heliyon. 2024; 10(8):e29504.
PMID: 38655349
PMC: 11036061.
DOI: 10.1016/j.heliyon.2024.e29504.
Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing.
Sun J, Zhang X, Wu F, Zhu B, Xie H
BMC Urol. 2024; 24(1):84.
PMID: 38600527
PMC: 11007970.
DOI: 10.1186/s12894-024-01478-9.
A novel batch-effect correction method for scRNA-seq data based on Adversarial Information Factorization.
Monnier L, Cournede P
PLoS Comput Biol. 2024; 20(2):e1011880.
PMID: 38386700
PMC: 10914288.
DOI: 10.1371/journal.pcbi.1011880.
An Analysis Regarding the Association Between DAZ Interacting Zinc Finger Protein 1 (DZIP1) and Colorectal Cancer (CRC).
Zhang Y, Liu Y, Mei J, Yang Z, Qian X, Huang W
Mol Biotechnol. 2024; 67(2):527-547.
PMID: 38334905
DOI: 10.1007/s12033-024-01065-1.
Prognostic implication of a novel lactate score correlating with immunotherapeutic responses in pan-cancer.
Deng Y, Zhu G, Mi X, Jing X
Aging (Albany NY). 2024; 16(1):820-843.
PMID: 38198170
PMC: 10817381.
DOI: 10.18632/aging.205423.
Omics data integration in computational biology viewed through the prism of machine learning paradigms.
Fouche A, Zinovyev A
Front Bioinform. 2023; 3:1191961.
PMID: 37600970
PMC: 10436311.
DOI: 10.3389/fbinf.2023.1191961.
The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
Yao K, Zhang R, Li L, Liu M, Feng S, Yan H
Front Immunol. 2023; 14:1181370.
PMID: 37600770
PMC: 10433769.
DOI: 10.3389/fimmu.2023.1181370.